The Journal of Nutritional Biochemistry
Volume 21, Issue 7 , Pages 621-626, July 2010

Peroxisome proliferator-activated receptors γ and α agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase

  • Xiaoyan Xiao

      Affiliations

    • Department of Endocrinology, Qilu Hospital, Shandong University, Jinan 250012, P.R. China
    • These two authors contributed equally to this work.
  • ,
  • Guohai Su

      Affiliations

    • Department of Cardiology, Jinan Central Hospital, Shandong University, Jinan 250013, P.R. China
    • These two authors contributed equally to this work.
  • ,
  • Stacey N. Brown

      Affiliations

    • Section of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT 06520, USA
  • ,
  • Li Chen

      Affiliations

    • Department of Endocrinology, Qilu Hospital, Shandong University, Jinan 250012, P.R. China
  • ,
  • Jianmin Ren

      Affiliations

    • Department of Endocrinology, Qilu Hospital, Shandong University, Jinan 250012, P.R. China
  • ,
  • Peng Zhao

      Affiliations

    • Department of Cardiology, Shandong Provincial Hospital, Shandong University, Jinan 250021, P.R. China
    • Corresponding Author InformationCorresponding author. Tel.: +86 011 531 85186416; fax: +86 011 531 85186306.

Received 8 October 2008; received in revised form 9 March 2009; accepted 10 March 2009. published online 02 July 2009.

Abstract 

Myocardial energy and glucose homeostasis are crucial for normal cardiac structure and function. Peroxisome proliferator-activated receptors (PPARs) play an important role in controlling transcriptional expression of key enzymes that are involved in glucose metabolism, and they have been demonstrated to significantly reduce tissue injury in cardiovascular diseases. Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a sensor that maintains intracellular energy homeostasis and mediates a number of physiological signals. It has been reported that AMPK promotes glucose uptake. We hypothesize that PPARγ and α agonists may play a role in the regulation of glucose metabolism through AMPK. We tested this hypothesis by using isolated papillary muscles of rat hearts treated with PPARγ and α agonists, troglitazone and GW7647, respectively. Our results demonstrated that both troglitazone and GW7647 significantly stimulated 2-deoxyglucose uptake of cardiac muscles. Interestingly, both agonists stimulated phosphorylation of AMPK and its downstream protein target acetyl-CoA carboxylase. Endothelial nitric oxide synthase (eNOS) was also activated by both agonists. In addition, AMPK activator 5-amino-4-imidazole-1-β-D-carboxamide ribofuranoside increased glucose uptake, while AMPK inhibitor compound C and NOS inhibitor, Nω-nitro-l-arginine, significantly blocked troglitazone- and GW7647-stimulated glucose uptake in cardiac muscles. There was also a reduction of glucose uptake with a marked decrease in AMPK and eNOS phosphorylation. In conclusion, both PPARγ and α activation play a role in the regulation of glucose uptake in cardiac muscles and this regulation is mediated by the AMPK and eNOS signaling pathways.

Keywords: Peroxisome proliferator-activated receptors, Left ventricular papillary muscles, Glucose uptake, AMP-activated protein kinase, Endothelial nitric oxide synthase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Support: This work was supported in part by the Natural Science Foundation of Shandong Province (#Y2002C47), Jinan Rising-Star Program (#07112) and Key Technologies R & D Program of Jinan, Shandong Province, China (#200705089-4).

PII: S0955-2863(09)00078-3

doi:10.1016/j.jnutbio.2009.03.011

The Journal of Nutritional Biochemistry
Volume 21, Issue 7 , Pages 621-626, July 2010